The Study of Cellular and Molecular Mechanism of the Combination Therapy Using Gukangling Decoction and Technetium[99tc] Methylene Diphosphonate for Glucocorticoid-Induced Osteoporosis

徐小雅,金慰芳,高建军,周轶,高克加

DOI: https://doi.org/10.3969/j.issn.1006-7108.2011.09.016

2011-01-01

Abstract:Objective To observe the cellular and molecular mechanism of the better effect of the combination therapy using Gukangling and technetium methylene diphosphonate(99Tc-MDP) for glucocorticoid-induced osteoporosis than that of signal therapy.Methods SD Rats were randomly divided into DEX group,DEX-MDP group(2 mg/kg MDP),DEX-Z group(2 mg/kg Gukangling),and DEX-MDP-Z group.At the end of drug administration,blood from carotids of all rats was collected to produce drug containing serum.The effects on the proliferation and differentiation of osteoblasts were detected using MTT and PNPP methods.The effects on the number and function of osteoclasts were detected using the TRAP methods and observation of lacuna on bone slips.Rat bone marrow cells were collected from the femur.The expressions of RUNX2 and PPARγ of the bone marrow cells were detected using real-time PCR method.Results Compared with the control group and the single therapy group,the combination therapy slightly promoted osteoblast differentiation,and strongly inhibited osteoclast number and osteoclastic bone absorption.The combination therapy also enhanced the ratio of RUNX2 and PPARγ.Conclusion The combination therapy using Gukangling and 99Tc-MDP can effectively inhibit osteoclast number and osteoclast function,and can promote differentiation of bone marrow mesenchymal cells into osteoblast precursors.This may be one of the reasons for the superior of combination therapy over single therapy.